Exploration of quantitative site‐specific serum O‐glycoproteomics with isobaric labeling for the discovery of putative O‐glycoprotein biomarkers-Reference-Cited by-同舟云学术

Exploration of quantitative site‐specific serum O‐glycoproteomics with isobaric labeling for the discovery of putative O‐glycoprotein biomarkers

Published:2022-05-11 Issue:6 Volume:16 Page:2100095
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Proteomics Clinical Apps

Author:

Zhang Zihan¹,Xu Hua²,Tian Zhixin¹^ORCID

Affiliation:

1. School of Chemical Science & Engineering Shanghai Key Laboratory of Chemical Assessment and Sustainability Tongji University Shanghai China

2. Department of Plastic and Reconstructive Surgery Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.202100095

Reference65 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Predictive Markers in Breast and Other Cancers: A Review

3. Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of N‐ and O‐linked site‐specific glycosylation by ion mobility mass spectrometry: State of the art and future directions;PROTEOMICS;2024-01-03

2. Gain-of-glycosylation in breast multi-drug-resistant MCF-7 adenocarcinoma cells and cancer stem cells characterized by site- and structure-specific N-glycoproteomics;Analytica Chimica Acta;2023-04

3. Advances in plasma proteomics: Moving from technology to precision medicine;PROTEOMICS – Clinical Applications;2022-11